Vertex Pharmaceuticals is set to report its first-quarter results next month, and analysts are expecting high single-digit ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.

Agena Bioscience, a global provider of molecular genomics solutions, recently announced the launch of the CFTR 100+ Panel, a multiplex genotyping solution designed to provide expanded coverage of CFTR ...

About Sionna Therapeutics Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel ...

Vertex Pharmaceuticals stock is a "Strong Buy", driven by robust CF franchise growth and successful label expansions for ...

The FDA has expanded indications for two targeted combination treatments, Alyftrek and Trikafta, that will now benefit more ...

This biotech innovator in cystic fibrosis therapies reported a notable insider sale, as disclosed in recent SEC filings.

Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.

TSN Sports curling play-by-play icon Vic Rauter has announced his retirement following a distinguished career that has ...

An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder. Boehringer ...

After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast enough to save the sick?